Quality of Life During Treatment With Chemohormonal Therapy: Analysis of E3805 Chemohormonal Androgen Ablation Randomized Trial in Prostate Cancer. [electronic resource]
Producer: 20190729Description: 1088-1095 p. digitalISSN:- 1527-7755
- Adenocarcinoma -- drug therapy
- Androgen Antagonists -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Docetaxel -- administration & dosage
- Humans
- Male
- Pain Measurement
- Prostatic Neoplasms -- drug therapy
- Quality of Life
- Surveys and Questionnaires
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.